Overview
Cerebellar ataxia, deafness, and myoclonus syndrome, often associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), is a hereditary condition characterized by neurological deficits including cognitive decline, movement disorders, and vascular complications 1.Diagnosis
Genetic Testing: Identification of mutations in the Notch3 gene, particularly novel mutations affecting exon 16, can confirm diagnosis 2.
Neuroimaging: MRI showing diffuse hyperintense signals in subcortical white matter and basal ganglia supports the diagnosis 3.
Skin Biopsy: Presence of PAS-positive granules and thickened dermal vessels can further validate the diagnosis 3.Management
Supportive Care: Focus on managing symptoms such as cognitive decline, movement disorders, and vascular complications through multidisciplinary approaches 1.
Preventive Measures: Regular monitoring for cardiovascular risks and management of secondary complications (e.g., venous insufficiency) 2.Special Populations
Elderly: Age is a significant predictor of clinical deterioration, necessitating closer monitoring and tailored management strategies 1.Key Recommendations
Genetic Testing for Notch3 Mutations: Essential for confirming CADASIL diagnosis (Evidence: Moderate 23).
MRI for Subcortical Lesions: Routine neuroimaging to identify characteristic white matter changes (Evidence: Moderate 3).
Close Monitoring in Older Patients: Given increased risk of clinical decline with age, elderly patients require more frequent assessments (Evidence: Moderate 1).References
1 Caeiro L, Ferro JM. Cognitive profile in CADASIL patients. Journal of neurology, neurosurgery, and psychiatry 2006. link
2 Saiki S, Sakai K, Saiki M, Kitagawa Y, Umemori T, Murata K et al.. Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene. Neurology 2006. link
3 Panagariya A, Sharma B, Shubhakaran. CADASIL in a family from north-west India. The Journal of the Association of Physicians of India 2004. link